SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-011150
Filing Date
2017-02-27
Accepted
2017-02-27 11:51:57
Documents
3
Period of Report
2017-02-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v460116_8-k.htm 8-K 23834
2 EXHIBIT 99.1 v460116_ex99-1.htm EX-99.1 9140
3 GRAPHIC logo.jpg GRAPHIC 2346
  Complete submission text file 0001144204-17-011150.txt   37712
Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Filer) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35112 | Film No.: 17640312
SIC: 2836 Biological Products, (No Diagnostic Substances)